Patent · US Active

Nucleic acid-based tests for RhD typing, gender determination and nucleic acid quantification

US8551707B2 · kind B2 · utility

17Cited by

58References

2Claims

0Family size

Assignee

Sequenom, Inc. · US

Inventors

Paul Andrew Oeth · San Diego, US
Mathias Ehrich · San Diego, US

Key dates

Filing date	Dec 12, 2011
Grant date	Oct 8, 2013
Priority date	—
Expiry date	Dec 12, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/16
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention in part provides nucleic acid-based assays, which are particularly useful for non-invasive prenatal testing. The invention in part provides compositions and methods for RhD typing, detecting the presence of fetal nucleic in a sample, determining the relative amount of fetal nucleic acid in a sample and determining the sex of a fetus, wherein each of the assays may be performed alone or in combination.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.